Filing Flows

Filing Flows › 8-K events › Health In Tech

Health In Tech: departure or appointment of directors and officers

Form 8-K filed Oct 26, 2026 · items 5.02, 7.01

CEO changesHealth In Tech Appoints Sanjay Shrestha as Chief Executive Officer to Lead Next Phase of Growth and Strategic Expansion

What the filing says

On October 20, 2026, the Board of Directors (the “Board”) of Health In Tech, Inc. (the “Company” or “Health In Tech”) appointed Sanjay Shrestha to serve as the Chief Executive Officer of the Company, effective as of such date (the “Effective Date”). Shrestha succeeds Tim Johnson, the Company’s founder, who ceased servi

Read the filing on SEC EDGAR →

What usually followsAcross 39,174 8-Ks reporting Item 5.02 (directors and officers: departures, appointments, pay) in our universe, the stock's median move the next session was −0.1% (typical size ±1.4%, up 48% of the time); over the following 21 sessions, +0.7%. Every item ranked →

What this kind of filing means

Item 5.02 — Departure or appointment of directors and officers. Leadership changes: who leaves, who arrives and on what terms. A sudden CEO or CFO departure without a successor deserves attention.

Health In Tech at a glance

Latest quarterQ2 2026
Revenue$8.1M
Revenue Y/Y-14%
Operating margin-41.2%
IndustryInsurance Agents, Brokers & Service

Health In Tech, Q2 2026: revenue $8.1M (-14% year over year), operating margin -41.2%. The chart follows the revenue to costs, profit and cash.

Health In Tech: every quarter, Q/Q and Y/Y, holders and guidance →

Health In Tech’s other material 8-Ks

Other recent ceo changes

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.